Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Human Molecular Genetics |
| Vol/bind | 18 |
| Udgave nummer | 10 |
| Sider (fra-til) | 1869-78 |
| Antal sider | 9 |
| ISSN | 0964-6906 |
| DOI | |
| Status | Udgivet - 2009 |
Bibliografisk note
Keywords: Adult; Aged; Carrier Proteins; Caspases; Chromosomes, Human, Pair 18; European Continental Ancestry Group; Female; Gene Deletion; Genotype; Humans; Loss of Heterozygosity; Middle Aged; Nuclear Proteins; Ovarian Neoplasms; Polymorphism, Single Nucleotide; SurvivalAdgang til dokumentet
Biblioteksadgang?
Tjek tilgængelighed hos det Kgl. BibliotekCitationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
I: Human Molecular Genetics, Bind 18, Nr. 10, 2009, s. 1869-78.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival
AU - Quaye, Lydia
AU - Dafou, Dimitra
AU - Ramus, Susan J
AU - Song, Honglin
AU - Gentry-Maharaj, Aleksandra
AU - Maharaj, Aleksandra Gentry
AU - Notaridou, Maria
AU - Hogdall, Estrid
AU - Kjaer, Susanne Kruger
AU - Christensen, Lise
AU - Hogdall, Claus
AU - Easton, Douglas F
AU - Jacobs, Ian
AU - Menon, Usha
AU - Pharoah, Paul D P
AU - Gayther, Simon A
N1 - Keywords: Adult; Aged; Carrier Proteins; Caspases; Chromosomes, Human, Pair 18; European Continental Ancestry Group; Female; Gene Deletion; Genotype; Humans; Loss of Heterozygosity; Middle Aged; Nuclear Proteins; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Survival
PY - 2009
Y1 - 2009
N2 - Common germline genetic variation and/or somatic alterations in tumours may be associated with survival in women diagnosed with ovarian cancer. The successful identification of genetic associations relies on a suitable strategy for identifying and testing candidate genes. We used microcell-mediated chromosome transfer approach and expression microarray analysis to identify genes that were associated with neoplastic suppression in ovarian cancer cell lines. Sixty-five tagging single nucleotide polymorphisms (tSNPs) in nine candidate genes were genotyped in approximately 1700 invasive ovarian cancer cases to look for associations with survival. For two of these genes, loss of heterozygosity (LOH) analysis of tSNPs in 314 ovarian tumours was used to identify associations between somatic gene deletions and survival. We identified significant associations with survival for a tSNP in caspase 5 (CASP5) [hazard ratio (HR) = 1.13 (95% CI: 1.00-1.27), P = 0.042] and two tSNPs in the retinoblastoma binding protein (RBBP8) gene [HR = 0.85 (95% CI: 0.75-0.95), P = 0.007 and HR = 0.83 (95% CI: 0.71-0.95), P = 0.009]. After adjusting for multiple prognostic factors in a multivariate Cox regression analysis, both associations in RBBP8 remained significant (P = 0.028 and 0.036). We then genotyped 314 ovarian tumours for several tSNPs in CASP5 and RBBP8 to identify gene deletions by LOH. For RBBP8, 35% of tumours in 101 informative cases showed somatic allelic deletion; LOH of RBBP8 was associated with a significantly worse prognosis [HR = 2.19 (95% CI: 1.36-3.54), P = 0.001]. In summary, a novel in vitro functional approach in ovarian cancer cells has identified RBBP8 as a gene for which both germline genetic variation and somatic alterations in tumours are associated with survival in ovarian cancer patients.
AB - Common germline genetic variation and/or somatic alterations in tumours may be associated with survival in women diagnosed with ovarian cancer. The successful identification of genetic associations relies on a suitable strategy for identifying and testing candidate genes. We used microcell-mediated chromosome transfer approach and expression microarray analysis to identify genes that were associated with neoplastic suppression in ovarian cancer cell lines. Sixty-five tagging single nucleotide polymorphisms (tSNPs) in nine candidate genes were genotyped in approximately 1700 invasive ovarian cancer cases to look for associations with survival. For two of these genes, loss of heterozygosity (LOH) analysis of tSNPs in 314 ovarian tumours was used to identify associations between somatic gene deletions and survival. We identified significant associations with survival for a tSNP in caspase 5 (CASP5) [hazard ratio (HR) = 1.13 (95% CI: 1.00-1.27), P = 0.042] and two tSNPs in the retinoblastoma binding protein (RBBP8) gene [HR = 0.85 (95% CI: 0.75-0.95), P = 0.007 and HR = 0.83 (95% CI: 0.71-0.95), P = 0.009]. After adjusting for multiple prognostic factors in a multivariate Cox regression analysis, both associations in RBBP8 remained significant (P = 0.028 and 0.036). We then genotyped 314 ovarian tumours for several tSNPs in CASP5 and RBBP8 to identify gene deletions by LOH. For RBBP8, 35% of tumours in 101 informative cases showed somatic allelic deletion; LOH of RBBP8 was associated with a significantly worse prognosis [HR = 2.19 (95% CI: 1.36-3.54), P = 0.001]. In summary, a novel in vitro functional approach in ovarian cancer cells has identified RBBP8 as a gene for which both germline genetic variation and somatic alterations in tumours are associated with survival in ovarian cancer patients.
U2 - 10.1093/hmg/ddp107
DO - 10.1093/hmg/ddp107
M3 - Journal article
C2 - 19270026
SN - 0964-6906
VL - 18
SP - 1869
EP - 1878
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 10
ER -